id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-316432-xemz7zn9	Talaie, Haleh	Is there any potential management against COVID-19? A systematic review and meta-analysis	2020-08-18		.txt	text/plain	5089	261	38	METHODS: Pubmed, Embase, Scopus, Cochrane, and Scholar databases were searched from inception to July 1, 2020, to identify studies reporting the current treatment process and medications (e.g. hydroxychloroquine, antiviral therapy, convalescent plasma, and immunomodulatory agents) for COVID-19. Zhong et al., provided a systematic review and meta-analysis including the therapies for severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome (MERS) mainly besides COVID-19 and assessed their safety and efficacy profiles [31] . All types of studies i.e. randomized controlled trials (RCTs), prospective or retrospective cohort studies, and the case series that investigated clinical outcomes and/or viral clearance among adult patients were included to conduct this study. In agreement with previous researches, our meta-analysis results showed that the administration of immunomodulatory agents (especially tocilizumab and anakinra) significantly decreased the mortality rate and ameliorate clinical symptoms in patients with COVID-19 [113, 114] . Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: a systematic review and meta-analysis	./cache/cord-316432-xemz7zn9.txt	./txt/cord-316432-xemz7zn9.txt